Tag: Cancer: Ovarian
Johnson & Johnson Will Pay $6.5 Billion to Settle Talc Ovarian Cancer Lawsuits
Early Diagnosis of High-Grade Serous Ovarian Cancer Feasible
Copy number profile abnormality values of DNA extracted from Pap samples higher from pre-HGSOC than healthy women
Mirvetuximab Soravtansine-Gynx Beneficial for FRα-Positive Ovarian Cancer
Longer progression-free survival seen, and significantly more patients had objective response than those receiving chemo
Cell-Free DNA Methylation Liquid Biopsy Discriminates Ovarian Cancer
OvaPrint classifier achieves accuracy of 91 percent, surpassing other commercial tests
Premenopausal Bilateral Oophorectomy Linked to Chronic Conditions
More chronic conditions seen in late midlife for women with history of PBO with or without hysterectomy
Aerobic Exercise Cuts Chemotherapy-Induced Peripheral Neuropathy Symptoms
Findings seen for women treated for ovarian cancer, with bigger improvement for those with symptoms at baseline
Are Specific Occupational Exposures Linked to Ovarian Cancer?
Increased odds ratios observed for employment as accountants; hairdressers, beauticians, and related workers; sewers and embroiderers
Fibroids, Endometriosis Tied to Higher Ovarian Cancer Risk
Hysterectomy modifies risk for cancer but not equally for Black and White women and for both conditions
Johnson & Johnson Agrees to $8.9 Billion Settlement in Talcum Powder Lawsuit
Company plans to stop selling the product globally this year
Older Women Still at Risk for Cancer With BRCA1/2 Mutations
Risk reduction surgeries before age 50 years substantially cut later cancer risk for those with genetic risk
